Dergiler / Erciyes Medical Journal / 2017 / Cilt: 39 - Sayı: 4

Percutaneous Ethanol Sclerotherapy of Venous Malformations of the Oral Cavity and the Oropharynx

Sayfa
183–188
DOI
—
🏛️Bu makalenin bibliyografik verileri ve tam metin bağlantısı DergiPark üzerinden sağlanmıştır.
DergiPark Kaydı ↗
✨

Yapay Zeka Hızlı Bakış & Çıkarımlar

AI Insight
⚡ TL;DR(1 Cümlede Hızlı Çıkarım)

In 1 patient, ulceration and cleavage on the tongue was resolved within 15 days after emergence.Conclusion: Percutaneous ethanol sclerotherapy is a reliable and efficacious method of treating venous malformations of the oral cavity and oropharynx.

📌 3 Maddede Bu Makale

🎯
Amaç & Hipotez:Objective: Percutaneous ethanol sclerotherapy has shown to be efficient in treating venous malformations of the head and neck.
📊
Temel Bulgular & Veri:Our aim was to assess the safety and efficacy of percutaneous ethanol sclerotherapy in treating venous malformations of the oral cavity and the oropharynx.Materials and Methods: From 2007 to 2015, 57 percutaneous procedures using ethanol were performed in 13 patients.
💡
Sonuç & Katkı:In 1 patient, ulceration and cleavage on the tongue was resolved within 15 days after emergence.Conclusion: Percutaneous ethanol sclerotherapy is a reliable and efficacious method of treating venous malformations of the oral cavity and oropharynx.
🔬Tür:Araştırma Makalesi
📍Kapsam:2007 Verileri
⚙️Değişkenler:Alan Parametreleri

Abstract

Objective: Percutaneous ethanol sclerotherapy has shown to be efficient in treating venous malformations of the head and neck. Our aim was to assess the safety and efficacy of percutaneous ethanol sclerotherapy in treating venous malformations of the oral cavity and the oropharynx.Materials and Methods: From 2007 to 2015, 57 percutaneous procedures using ethanol were performed in 13 patients. Medical records of these patients were retrospectively analyzed. One patient was male and 12 were females. The patients' age ranged from 8 to 65 years (mean age, 30 years). The mean follow-up was 11 months. The volume of ethanol used per session ranged from 0.4 to 14 mL (mean volume, 6 mL) in 12 patients, except the syndromic patient.Results: In 7 out of 13 patients (53.4%), the lesions were resolved completely. In 3 patients (23%), sclerotherapy alleviated the symptoms. In 2 patients (15.3%), the lesions did not sufficiently respond to the therapy. In 1 patient (7.6%), sclerotherapy failed due to misdiagnosis. No major complications were encountered. All the patients experienced pain to a tolerable degree. Swelling, induration, and darkening of the lesion occurred following injections. In 1 patient, ulceration and cleavage on the tongue was resolved within 15 days after emergence.Conclusion: Percutaneous ethanol sclerotherapy is a reliable and efficacious method of treating venous malformations of the oral cavity and oropharynx.

🔖

Bu Makaleye Atıf Yap

AKAN, H., UZUNKAYA, F., SOYLU, A. İ. (2017). Percutaneous Ethanol Sclerotherapy of Venous Malformations of the Oral Cavity and the Oropharynx. Erciyes Medical Journal, Cilt: 39 - Sayı: 4, 183–188. https://ajindex.com/articles/223483

📄 Tam Metin PDF Okuyucu

📄

PDF görüntüleyici hazırlanıyor...

Kaynakça (15)

  1. Greene AK. Vascular anomalies: current overview of the field. Clin Plast Surg 2011
  2. 38(1): 1-5. [CrossRef] 2. Cox JA, Bartlett E, Lee EI. Vascular Malformations: A Review. Semin Plast Surg 2014
  3. 28(2): 58-63. [CrossRef] 3. Johnson PL, Eckard DA, Brecheisen MA, Girod DA, Tsue TT. Percutaneous ethanol sclerotherapy of venous malformations of the tongue. AJNR Am J Neuroradiol 2002
  4. 23(5): 779-82. 4. Donnelly LF, Adams DM, Bisset GS. Vascular malformations and hemangiomas: a practical approach in a multidisciplinary clinic. AJR Am J Roentgenol 2000
  5. 174(3): 597-608. [CrossRef] 5. Hassanein AH, Mulliken JB, Fishman SJ, Alomari AI, Zurakowski D, Greene AK. Venous malformation: risk of progression during childhood and adolescence. Ann Plast Surg 2012
  6. 68(2): 198-201. [CrossRef] 6. Greene AK, Liu AS, Mulliken JB, Chalache K, Fishman SJ. Vascular anomalies in 5,621 patients: guidelines for referral. J Pediatr Surg 2011
  7. 46(9): 1784-9. [CrossRef] 7. Pappas DC Jr, Persky MS, Berenstein A. Evaluation and treatment of head and neck venous vascular malformations. Ear Nose Throat J 1998
  8. 77(11): 914-22. 8. Chim H, Drolet B, Duffy K, Koshima I, Gosain AK. Vascular anomalies and lymphedema. Plast Reconstr Surg 2010
  9. 126(2): 55e-69e. [CrossRef] 9. Enjolras O, Mulliken JB. The current management of vascular birthmarks. Pediatr Dermatol 1993
  10. 10(4): 311-33. [CrossRef] 10. Kim KH, Sung MW, Roh JL, Han MH. Sclerotherapy for congenital lesions in the head and neck. Otolaryngol Head Neck Surg 2004
  11. 131(3): 307-16. [CrossRef] 11. Lee CH, Chen SG. Direct perc utaneous ethanol instillation for treatment of venous malformation in the face and neck. Br J Plast Surg 2005
  12. 58(8): 1073-8. [CrossRef] 12. Lee BB, Do YS, Byun HS, Choo IW, Kim DI, Huh SH. Advanced management of venous malformation with ethanol sclerotherapy: mid-term results. J Vasc Surg 2003
  13. 37(3): 533-8. [CrossRef] 13. Gelbert F, Enjolras O, Deffrenne, Aymard A, Mounayer C, Merland JJ. Percutaneous sclerotherapy for venous malformations of the lips: a retrospective study of 23 patients. Neuroradiology 2000
  14. 42(9): 692- 6. [CrossRef] 14. Wassef M, Blei F, Adams D, Alomari A, Baselga E, Berenstein A, et al. Vascular Anomalies Classification: Recommendations From the International Society for the Study of Vascular Anomalies. Pediatrics 2015
  15. 136(1): e203-14. [CrossRef] 15. Lo Casto A, Salerno S, Cannizzaro F, Caronia A, Bencivinni F, Barbiera F, et al. MRI findings in lingual venous malformations. Dentomaxillofac Radiol 2